Pharmaceutical imports were 9.9% of U.S. consumption, trade surplus was $793 mil. in 1993 -- ITC.
Executive Summary
PHARMACEUTICAL IMPORTS ACCOUNTED FOR 9.9% OF CONSUMPTION IN U.S. IN 1993, a slight decline from the 1992 rate of 10.3%, according to a recent report by the International Trade Commission entitled "Industry & Trade Summary: Medicinal Chemicals, Except Antibiotics." The level of imports in 1993 represented an increase over the 8.2% rate in 1989. In 1993, the report states, total U.S. consumption was an estimated $49.43 bil., while the value of imports was $4.9 bil.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth